{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:47:56Z","timestamp":1791244076364,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["HHSN272201100030C"],"award-info":[{"award-number":["HHSN272201100030C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Glycobiology Institute Endowment"},{"name":"Emergent BioSolutions"},{"name":"Lerner-Fink Fellowship"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097300\/Z\/11\/Z"],"award-info":[{"award-number":["097300\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["105402\/Z\/14\/Z"],"award-info":[{"award-number":["105402\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institutional Animal Care and Use Committee","award":["AP028-SS1-0615"],"award-info":[{"award-number":["AP028-SS1-0615"]}]},{"DOI":"10.13039\/100006978","name":"UC Berkeley","doi-asserted-by":"publisher","award":["R252-1012B"],"award-info":[{"award-number":["R252-1012B"]}],"id":[{"id":"10.13039\/100006978","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS National Research Ethics Service","award":["09\/H0606\/3"],"award-info":[{"award-number":["09\/H0606\/3"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.antiviral.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T04:22:08Z","timestamp":1456978928000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Inhibition of endoplasmic reticulum glucosidases is required for in\u00a0vitro and in\u00a0vivo dengue antiviral activity by the iminosugar UV-4"],"prefix":"10.1016","volume":"129","author":[{"given":"Kelly L.","family":"Warfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Sayce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic S.","family":"Alonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-6419","authenticated-orcid":false,"given":"Beatrice E.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro T.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Killingbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Robert","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Kinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Kiappes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoora","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Treston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Enterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Zitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Ramstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Shresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/BJ20070748","article-title":"Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition","volume":"409","author":"Alonzi","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/jm970836l","article-title":"Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases","volume":"41","author":"Asano","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.antiviral.2013.06.011","article-title":"Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions","volume":"99","author":"Chang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.001_bib6","first-page":"880","article-title":"Advances in flavivirus vaccine development","volume":"13","author":"Coller","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.antiviral.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/0-387-25515-X_3","article-title":"The bovine viral diarrhoea virus: a model for the study of antiviral molecules interfering with N-glycosylation and folding of envelope glycoprotein","volume":"564","author":"Durantel","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach. Nature reviews","volume":"1","author":"Dwek","year":"2002","journal-title":"Drug Discov."},{"key":"10.1016\/j.antiviral.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1002\/chem.201200110","article-title":"Scalable syntheses of both enantiomers of DNJNAc and DGJNAc from glucuronolactone: the effect of N-alkylation on hexosaminidase inhibition","volume":"18","author":"Glawar","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.antiviral.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.03.001_bib12","unstructured":"NCT02061358: Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single-Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects. U.S. National Institutes of Health https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02061358."},{"key":"10.1016\/j.antiviral.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3851\/IMP1690","article-title":"Important advances in the field of anti-dengue virus research","volume":"21","author":"Julander","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1128\/JCM.37.8.2543-2547.1999","article-title":"Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system","volume":"37","author":"Laue","year":"1999","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(98)00525-0","article-title":"Alpha-glucosidase inhibitors as potential broad based anti-viral agents","volume":"430","author":"Mehta","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","article-title":"Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling","volume":"331","author":"Neville","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2013.01.004","article-title":"An iminosugar with potent inhibition of dengue virus infection in\u00a0vivo","volume":"98","author":"Perry","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"269","author":"Platt","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1128\/JVI.00028-15","article-title":"Dengue virus evolution under a host-targeted antiviral","volume":"89","author":"Plummer","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jim.2014.01.001","article-title":"Mouse models for dengue vaccines and antivirals","volume":"410","author":"Plummer","year":"2014","journal-title":"J.\u00a0Immunol. methods"},{"key":"10.1016\/j.antiviral.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa1302846","article-title":"Glycosylation, hypogammaglobulinemia, and resistance to viral infections","volume":"370","author":"Sadat","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.03.001_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004524","article-title":"Iminosugars inhibit dengue virus production via inhibition of alpha-glucosidases - not glycoprotein processing enzymes","author":"Sayce","year":"2016","journal-title":"PLoS negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tim.2010.04.003","article-title":"Targeting a host process as an antiviral approach against dengue virus","volume":"18","author":"Sayce","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A\u00a0dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"e0121662","DOI":"10.1371\/journal.pone.0121662","article-title":"In\u00a0vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4","volume":"10","author":"Stavale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coviro.2015.04.007","article-title":"Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models","volume":"13","author":"Tang","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/v7052404","article-title":"A\u00a0novel iminosugar UV-12 with activity against the diverse viruses influenza and dengue (novel iminosugar antiviral for influenza and dengue)","volume":"7","author":"Warfield","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.03.001_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"Watanabe","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:18Z","timestamp":1759062378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":32,"alternative-id":["S0166354216301218"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of endoplasmic reticulum glucosidases is required for in\u00a0vitro and in\u00a0vivo dengue antiviral activity by the iminosugar UV-4","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}